Medicare Enrolled
Dr. Peter Lee, M.D.
Neurology · Lagrange, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Peter Lee is a neurology specialist in Lagrange, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 880 Medicare services across 396 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $14,770 from 76 pharmaceutical and/or device companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 31% volume in GA
$14,770 industry payments
Medicare Practice Summary
Medicare Utilization ↗880
Medicare services
Top 31% in GA for neurology
396
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
561 | $83 | $200 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
69 | $57 | $150 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
65 | $61 | $150 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
65 | $80 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $112 | $250 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
28 | $67 | $325 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
22 | $202 | $700 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $155 | $1,000 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $104 | $500 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $318 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,770
Total received (2018-2024)
Avg $2,110/year across 7 years
Top 20% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
697
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,770 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,225
2023
$3,167
2022
$1,994
2021
$2,383
2020
$1,694
2019
$1,620
2018
$1,686
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$290
Neurocrine Biosciences, Inc.
$207
SCILEX PHARMACEUTICALS INC.
$190
ABBVIE INC.
$139
Abbott Laboratories
$128
EMD Serono, Inc.
$125
PFIZER INC.
$116
UCB, Inc.
$113
Biogen, Inc.
$102
Lilly USA, LLC
$97
SHIELD THERAPEUTICS INC
$90
ANI Pharmaceuticals, Inc.
$87
Amgen Inc.
$65
Novo Nordisk Inc
$63
Lundbeck LLC
$53
ARGENX US, INC.
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Alexion Pharmaceuticals, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$38
AstraZeneca Pharmaceuticals LP
$33
Teva Pharmaceuticals USA, Inc.
$28
CSL Behring
$27
Amneal Pharmaceuticals LLC
$26
SK Life Science, Inc.
$24
Otsuka America Pharmaceutical, Inc.
$21
Axsome Therapeutics, Inc.
$18
Top 3 companies account for 30.9% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,542
Lilly USA, LLC
$914
Amgen Inc.
$868
EMD Serono, Inc.
$780
ABBVIE INC.
$604
Novartis Pharmaceuticals Corporation
$596
Novo Nordisk Inc
$465
Greenwich Biosciences, Inc.
$456
Teva Pharmaceuticals USA, Inc.
$445
Eisai Inc.
$437
Biohaven Pharmaceuticals, Inc.
$370
Boehringer Ingelheim Pharmaceuticals, Inc.
$341
Lundbeck LLC
$333
GENZYME CORPORATION
$328
Abbott Laboratories
$307
Supernus Pharmaceuticals, Inc.
$303
PFIZER INC.
$300
Neurocrine Biosciences, Inc.
$272
Avanir Pharmaceuticals, Inc.
$243
Biogen, Inc.
$242
SK Life Science, Inc.
$230
ANI Pharmaceuticals, Inc.
$190
SCILEX PHARMACEUTICALS INC.
$190
UCB, Inc.
$180
Sunovion Pharmaceuticals Inc.
$175
AstraZeneca Pharmaceuticals LP
$167
Biohaven Pharmaceutical Holding Company Ltd.
$164
Allergan Inc.
$164
CSL Behring
$162
AbbVie Inc.
$160
Amneal Pharmaceuticals LLC
$145
SANOFI-AVENTIS U.S. LLC
$136
Scilex Pharmaceuticals Inc.
$130
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$128
Janssen Pharmaceuticals, Inc
$127
JAZZ PHARMACEUTICALS INC.
$123
Merck Sharp & Dohme Corporation
$120
Harmony Biosciences LLC
$117
IMPEL PHARMACEUTICALS INC.
$115
DePuy Synthes Sales Inc.
$99
SHIELD THERAPEUTICS INC
$90
Amarin Pharma Inc.
$85
Alexion Pharmaceuticals, Inc.
$85
UPSHER-SMITH LABORATORIES LLC
$85
Allergan, Inc.
$83
ACADIA Pharmaceuticals Inc
$83
US WorldMeds, LLC
$81
Otsuka America Pharmaceutical, Inc.
$79
GlaxoSmithKline, LLC.
$76
Axsome Therapeutics, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$66
Alfasigma USA, Inc.
$64
Xeris Pharmaceuticals, Inc.
$62
IDORSIA PHARMACEUTICALS US INC
$56
ARGENX US, INC.
$50
Kyowa Kirin, Inc.
$45
Grifols USA, LLC
$43
Impax Laboratories, Inc.
$40
Neurelis, Inc.
$37
Esperion Therapeutics, Inc.
$30
Zyla Life Sciences
$29
Mallinckrodt Hospital Products Inc.
$27
AQUESTIVE THERAPEUTICS, INC.
$26
Mallinckrodt Enterprises LLC
$25
Brainsway USA Inc
$22
Catalyst Pharmaceuticals, Inc.
$22
GE HEALTHCARE
$19
Celgene Corporation
$17
Mallinckrodt LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Upsher-Smith Laboratories LLC
$16
Acorda Therapeutics, Inc
$13
Shield Therapeutics Inc
$13
EISAI INC.
$12
ARBOR PHARMACEUTICALS, INC.
$11
Neuronetics, Inc.
$8
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANORO · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · AVYCAZ · Aimovig · Austedo XR · BASAGLAR · BELSOMRA · BOTOX · BREO · BREZTRI · BYSTOLIC · Brainsway Deep TMS · Briviact · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COPAXONE · CREXONT · DALVANCE · Dayvigo · EMGALITY · ENTRESTO · EPIDIOLEX · Epidiolex · FARXIGA · FIRDAPSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · Fycompa · GEMTESA · GILENYA · GVOKE HYPOPEN · GVOKE PFS · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · JANUVIA · JARDIANCE · KESIMPTA · KISUNLA · Kerendia · LEQEMBI · LYRICA · LYUMJEV · Leqembi · MAVENCLAD · MAYZENT · MOUNJARO · Mavenclad · NEUROSTAR TMS THERAPY · NEXLETOL · NEXLIZET · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · ORTHOVISC · OXTELLAR XR · Ongentys · Otezla · Ozempic · PAXLOVID · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Sunosi · TEFLARO · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TYSABRI · Tresiba · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Victoza · Vimpat · Wakix · XIFAXAN · Xadago · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
2
Per 100K population
2.9
County median income
$54,905
Nearest hospital
WELLSTAR WEST GEORGIA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lee performed 561 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $14,770 from 76 companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other neurologists in Lagrange?
Dr. Lee's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lagrange
Browse neurologists in Lagrange ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology